Edoc Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 1.00 M
- Company Age 8 Year, 23 Days
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.16 Cr
- Revenue Growth 14.16%
- Profit Growth 17.35%
- Ebitda 8.27%
- Net Worth 28.92%
- Total Assets -10.34%
About Edoc Life Sciences
Edoc Life Sciences Private Limited (ELSPL) is a Private Limited Indian Non-Government Company incorporated in India on 03 February 2017 (Eight years 23 days old ). Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹1.16 Cr.
Chandra Sridara, Srinivasarao Jampa, and Ganesh Palepu serve as directors at the Company.
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24100TG2017PTC114416
- Company No.
114416
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
03 Feb 2017
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Pharma
Who are the key members and board of directors at Edoc Life Sciences?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Chandra Sridara  | Director | 03-Feb-2017 | Current |
| Srinivasarao Jampa | Additional Director | 09-Feb-2024 | Current |
| Ganesh Palepu | Director | 03-Feb-2017 | Current |
Financial Performance of Edoc Life Sciences.
Edoc Life Sciences Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 14.16% increase. The company also saw a substantial improvement in profitability, with a 17.35% increase in profit. The company's net worth Soared by an impressive increase of 28.92%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Edoc Life Sciences?
In 2023, Edoc Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
Open Charges
₹11.65 M
Satisfied Charges
₹0
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 1.16 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 20 Aug 2024 | Hdfc Bank Limited | ₹0.93 M | Open |
| 02 Nov 2023 | Hdfc Bank Limited | ₹1.52 M | Open |
| 06 Oct 2023 | Hdfc Bank Limited | ₹2.55 M | Open |
| 04 Jul 2022 | Hdfc Bank Limited | ₹1.66 M | Open |
| 10 Mar 2020 | Hdfc Bank Limited | ₹5.00 M | Open |
How Many Employees Work at Edoc Life Sciences?
Edoc Life Sciences has a workforce of 40 employees as of Mar 26, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Edoc Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Edoc Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.